Testing effectiveness (Phase 2)Study completedNCT00002751What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Brain MetastasesWho this might be right forMetastatic Cancer Duke University 6
Early research (Phase 1)Ended earlyNCT03416530What this trial is testingONC201 in Pediatric H3 K27M GliomasWho this might be right forDiffuse Intrinsic Pontine GliomaGlioma, Malignant Jazz Pharmaceuticals 134
Not applicableLooking for participantsNCT04075305What this trial is testingThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyWho this might be right forOncologyBreast CancerProstate Cancer+35 more UMC Utrecht 8,000
Early research (Phase 1)Study completedNCT00002754What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer Duke University 6
Early research (Phase 1)Study completedNCT00036959What this trial is testingABT-751 in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more National Institutes of Health Clinical Center (CC) 90
Not applicableNo Longer AvailableNCT03424473What this trial is testingExpanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer Seagen Inc.
Testing effectiveness (Phase 2)Study completedNCT01386580What this trial is testingAn Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.Who this might be right forBrain MetastasesLung CancerBreast Cancer+2 more BBB-Therapeutics B.V. 84
Not applicableStudy completedNCT03685539What this trial is testingDECT in Imaging Patients With Solid Organ Cancer With Intracranial MetastasisWho this might be right forMalignant NeoplasmMetastatic Malignant Neoplasm in the Brain M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00445965What this trial is testingIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT04388475What this trial is testingOpen-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent GlioblastomaWho this might be right forRecurrent Malignant GliomaBrain Glioblastoma Oblato, Inc. 57
Testing effectiveness (Phase 2)Study completedNCT01441596What this trial is testingLux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain MetastasesWho this might be right forBreast NeoplasmsNeoplasm Metastasis Boehringer Ingelheim 121
Testing effectiveness (Phase 2)Study completedNCT00616005What this trial is testingPh. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideWho this might be right forGlioblastoma Duke University 41
Early research (Phase 1)Study completedNCT01470794What this trial is testingStudy of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain TumorWho this might be right forGlioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more Tocagen Inc. 58
Early research (Phase 1)Study completedNCT00005951What this trial is testingIrinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Duke University
Testing effectiveness (Phase 2)Study completedNCT00028795What this trial is testingChemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine GliomaWho this might be right forBrain and Central Nervous System Tumors Children's Oncology Group 170
Early research (Phase 1)Study completedNCT03387020What this trial is testingRibociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain TumorsWho this might be right forCNS Embryonal Tumor, Not Otherwise SpecifiedMalignant GliomaRecurrent Atypical Teratoid/Rhabdoid Tumor+4 more Pediatric Brain Tumor Consortium 22
Testing effectiveness (Phase 2)WithdrawnNCT00003273What this trial is testingChemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain TumorWho this might be right forBrain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00470366What this trial is testingCombination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06377696What this trial is testingRemote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation TherapyWho this might be right forMalignant Brain Neoplasm Mayo Clinic 100
Not applicableLooking for participantsNCT06283927What this trial is testingThe RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)Who this might be right forGlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more Jasper Gerritsen 464